4 employees
Avalon BioVentures operates as a biotech venture capital firm.
$58M sweet spot round size
Most of their 1 investments are in rounds between $58M and $58M
2013
Arialys Therapeutics, Inc. raised $58M on September 12, 2023
Investors: MPM Capital, Catalys Pacific and Avalon BioVentures